Facade of Grifols headquarters, on March 9, 2023, in Coslada (Madrid). Specializing in the pharmaceutical and hospital sector, Grifols is a leading global healthcare company dedicated to the development of plasma-derived medicines
Grifols shares soar on possible sale of $1.5 billion stake in Shanghai RAAS | Reuters
Grifols Sinks as Short Seller Gotham Criticizes Accounting - Bloomberg
Media Resources
GRF SM) Grifols Set for Biggest Weekly Drop Ever on Short Seller Tumult - Bloomberg
Blood Group Typing Market is Booming Worldwide with | Grifols,
Grifols shares suffer worst week on record after short-seller report
Press release contact
Spanish healthcare group Grifols plunges 40% after fraud allegation
PSG féminin : l'entraîneur Ollé-Nicolle suspendu en raison d'un comportement «inapproprié»
Grifols on LinkedIn: Grifols announces changes in governance to separate management from… | 36 comments
GRIFOLS TO ADD 300 JOBS AS IT UNDERTAKES $351 MILLION EXPANSION TO ITS CLAYTON OPERATIONS | Johnston County Economic Development
Grifols announces comprehensive operational improvement plan including EUR 400 million annualized cost savings initiative
Selagine and Grifols Team Up for DED Eye Drops | OBN
What is Grifols and why have its shares slumped? -January 09, 2024 at 10:18 pm IST | MarketScreener
Grifols lifts 2023 margin outlook as revenue rises | Reuters
Grifols is the latest drugmaker to succumb to the layoff trend
Spain's Grifols to sue short-seller over critical report, shares jump | Reuters
Grifols on LinkedIn: Today, we held our annual shareholders' meeting with 536 shareholders…
Grifols to sue Gotham City Research for financial and reputational damage
g55411bci001.gif
Grifols reaches revenue of EUR 5,100 million, a 13.6% increase, and raises its profits to EUR 625 million
Grifols, S.A. Sponsored ADR Class B Aktie News
